转化生长因子β在动脉粥样硬化发生中的作用

沈绍群; 李林

沈绍群 , 李林

文章导航 > 国际放射医学核医学杂志 > 2004, 28 > 6: (256-259)

引用本文:

Citation:

转化生长因子β在动脉粥样硬化发生中的作用

沈绍群,
李林

200040 上海, 复旦大学华山医院核医学科
中图分类号: R543.5

Advances in study of atherosclerosis with transforming growth factor-β

Department of Nuclear Medicine, West China Hospital of Sichuan University, Sichuan Chengdu 610041, China
CLC number: R543.5

摘要: 随着生活方式、饮食结构的改变,动脉粥样硬化呈不断上升的趋势,其具体的发病机制不清。尽快找到确切的发病机制并进行有效地预防和治疗成为目前的关键所在。本文着重阐述转化生长因子β在动脉粥样硬化发生中抗炎症、促纤维化的作用。
- 转化生长因子β /
- 动脉粥样硬化
Abstract: With the changing of life style and dietary structure, the incidence of atherosclerosis, whose pathogenesis are not completely understood, tends to increase. Finding out positive pathogenesis and making effective precaution and therapy are present emphasis. The antiinflammation and profibrosis of TGF-β in the progress of atherosclerosis are reviewed in the article.
- transforming growth factor-β /
- atherosclerosis
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Chen C,Wang XF,Sun L,et al.Expression of TGF-β type III receptor restores autocrine TGF-β1 activity in human breast cancer MCF-7 cells[J].J Biol Chem,1997,272(19):12862-12867.
[2]	Massague J.TGF-β signal transduction[J].Annu Rev Biochem,1998,67:753-791.
[3]	Nakao A,Afrakhte M.Identification of Smas7,a TGF-β-inducible an-tagonist of TGF-β signaling[J].Nature,1997,389(6651):631-635.
[4]	Mallat Z,Gojova A,Marchiol-Fournigault C,et al.Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice[J].Circ Res,2001,89(10):930-934.
[5]	Argmann CA,Van Den Diepstraten CH,Sawyez CG,et al.Transforming growth factor-β1 inhibits macrophage cholesteryl ester accumulation induced by native and ox-idized V L D L remnants[J].Ar-terioscler Throm Vasc Biol,2001,21(12):2011-2018.
[6]	Zuckerman SH,Panousis C,Evans G.TGF-beta reduced binding of high-density lipoproteins in murine macrophages and macrophage-derived foam cells[J].Atherosclerosis,2001,155(1):79-85.
[7]	Minami M,Kume N,Kataoka H,et al.Transforming growth factor-beta(1) increases the expression of lectin-like oxidized low-density lipoprotein receptor-1[J].Biochem Biophys Res Commun,2000,272(2):357-361.
[8]	Oemar BS,Werner A,Garnier JM,et al.Human connective tissue growth factorIs expressedin advanced atherosclerotic lesions[J].Circulation,1997,95(4):831-839.
[9]	Tashiro H,Shimokawa H,Sadamatu K,et al.Prognostic significance of plasma concentrations of transforming growth factor-beta in patients with coronary artery disease[J].Coron Artery Dis,2002,13(3):139-143.
[10]	Feinberg M W,Jain MK,Werner F,et al.Transforming growth factor-beta 1 inhibits cytokine-mediated induction of human metalloelastase in macrophages[J].J Biol Chem,2000,275(33):25766-25773.
[11]	Leiro JM,Alvarez E,Arranz JA,et al.In vitro effects of mangiferin on superoxide concentrations and expression of the inducible nitric oxide synthase,tumour necrosis factor-alpha and transforming growth factor-beta genes[J].Biochem Pharmacol,2003,65(8):1361-1371.
[12]	Porreca E,Di-Febbo C,Baccante G,et al.Increased transforminggrowth factor-beta (1) circulating levels and production in human monocytes after 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase inhibition with pravastatin[J].J Am Coll Cardiol,2002,39(11):1752-1757.
[13]	Febbraio M,Guy E,Coburn C,et al.The impact of overexpression and deficiency of fatty acid translocase (FAT)/CD36[J].Mol Cell Biochem,2002,239(1-2):193-197.
[14]	Tsukazali T,Chiang TA,Davison AF,et al.SARA,a FYVE domain protein that recruits Smad2 to the TGFβ receptor[J].Cell,1998,95(6):779-791.
[15]	Gojova A,Brun V,Esposito B,et al.Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and compositionin mice[J].Blood,2003,102(12):4052-4058.
[16]	Chen X,Ren S,M a M G,et al.Hirulog-like peptide reduces restenosis and expression of tissue factor and transforming growth factor-beta in carotid artery of atherosclerotic rabbits[J].Atherosclerosis,2003,169(1):31-40.
[17]	Kintscher U,Lyon C,Wakino S,et al.PPARalpha inhibits TGF-beta-induced beta5 integrin transcription in vascular smooth muscle cells by interacting with Smad4[J].Circ Res,2002,91(11):e35-e44.
[18]	Su JZ,Fukuda N,Hu WY,et al.Ribozyme to human TGF-betal mRNA inhibits the proliferation of human vascular smooth muscle cells[J].Biochem Biophys Res Commun,2000,278(2):401-407.
[19]	Yamamoto K,Morishita R,Tomita N,et al.Ribozyme oligonucleotides against transforming growth factor-beta inhibited neointi-mal formation after vascular injury in rat model:potential application of ribozyme strategy to treat cardiovascular disease[J].Circu-lation,2000,102(11):1308-1314.
[20]	Saiura A,Sata M,Hirata Y,et al.Tranilast inhibits transplant-associated coronary arteriosclerosis in a murine model of cardiac transplantation[J].Eur J Pharmacol,2001,433(2-3):163-168.

[1]	侯朝华 , 常颖欧 , 魏健 , 娄永忠 , 张宁 . 多层螺旋CT血管造影术诊断动脉粥样硬化性肾动脉狭窄的价值. 国际放射医学核医学杂志, 2011, 35(5): 307-310. doi: 10.3760/cma.j.issn.1673-4114.2011.05.013
[2]	肖林林 , 金问森 , 张江虹 , 邵春林 . 电离辐射诱发动脉粥样硬化的研究进展. 国际放射医学核医学杂志, 2015, 39(6): 493-496. doi: 10.3760/cma.j.issn.1673-4114.2015.06.012
[3]	李帅 , 李剑明 . 动脉粥样硬化易损斑块放射性核素标记分子探针的研究进展. 国际放射医学核医学杂志, 2015, 39(1): 80-84. doi: 10.3760/cma.j.issn.1673-4114.2015.01.017
[4]	刘纯宝 , 兰晓莉 , 张永学 . 粥样硬化易损斑块传统影像与分子影像检测与评价现状. 国际放射医学核医学杂志, 2014, 38(2): 101-105, 134. doi: 10.3760/cma.j.issn.1673-4114.2014.02.008
[5]	王军英 , 涂彧 , 周菊英 , 徐晓婷 , 王利利 . 前列腺素E₁注射液对急性放射性肺损伤的保护作用. 国际放射医学核医学杂志, 2007, 31(2): 115-117.
[6]	张文雯 , 孙凯 . CT血管成像在心脑血管一站式成像中的研究进展. 国际放射医学核医学杂志, 2018, 42(2): 177-180, 188. doi: 10.3760/cma.j.issn.1673-4114.2018.02.014
[7]	张艳容 . 动脉粥样硬化斑块显像研究进展. 国际放射医学核医学杂志, 2004, 28(3): 109-113.
[8]	廖光祥 , 赵德明 , 刘秀杰 . 人体动脉粥样硬化的外部显影. 国际放射医学核医学杂志, 1984, 8(4): 250-251.
[9]	陆忠华 , 周菊英 , 许锡元 . 转化生长因子β1与放射性肺损伤. 国际放射医学核医学杂志, 2006, 30(4): 247-249.
[10]	张晓桂 , 陈静 , 潘伯荣 , 夏宗勤 . 肾近端动脉粥样硬化性狭窄MRI的可靠性. 国际放射医学核医学杂志, 1992, 16(5): 240-240.